Charles de Chasteigner du Mée
Private Equity Investor bij Accelerated Venture Partners LLC
Actieve functies van Charles de Chasteigner du Mée
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Accelerated Venture Partners LLC
Accelerated Venture Partners LLC Investment ManagersFinance Accelerated Venture Partners LLC (Accelerated Venture Partners) is a private equity firm founded in 2008. The firm is headquartered in San Mateo, California. | Private Equity Investor | 01-01-2008 | - |
Loopbaan van Charles de Chasteigner du Mée
Eerdere bekende functies van Charles de Chasteigner du Mée
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
REDWOOD PHARMA AB | Oprichter | 01-01-2012 | 02-01-2017 |
Private Equity Investor | 01-01-2012 | 02-01-2017 | |
President | 01-01-2012 | 02-01-2017 | |
Nascent Pharmaceuticals, Inc.
Nascent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nascent Pharmaceuticals, Inc. manufactured pharmaceuticals and drugs. The company was founded by Charles P. R. de C. du Mée and Gene Barnett in 1999 and was headquartered in Durham, NC. | Directeur/Bestuurslid | 01-05-1999 | - |
Oprichter | 01-01-1999 | 31-01-2008 | |
Corporate Officer/Principal | 01-05-1999 | - | |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Corporate Officer/Principal | 01-01-1990 | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 31-12-1989 | 31-12-1989 |
MONSANTO | Corporate Officer/Principal | 01-01-1983 | - |
Opleiding van Charles de Chasteigner du Mée
University of Florida | Doctorate Degree |
University of San Francisco | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 8 |
Zuid-Afrika | 2 |
Zweden | 2 |
Operationeel
Corporate Officer/Principal | 4 |
Founder | 2 |
Private Equity Investor | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 4 |
Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
REDWOOD PHARMA AB | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
University of Natal | Consumer Services |
Monsanto Co.
Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
Nascent Pharmaceuticals, Inc.
Nascent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nascent Pharmaceuticals, Inc. manufactured pharmaceuticals and drugs. The company was founded by Charles P. R. de C. du Mée and Gene Barnett in 1999 and was headquartered in Durham, NC. | Health Technology |
Accelerated Venture Partners LLC
Accelerated Venture Partners LLC Investment ManagersFinance Accelerated Venture Partners LLC (Accelerated Venture Partners) is a private equity firm founded in 2008. The firm is headquartered in San Mateo, California. | Finance |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |